Marlies Stützle‐Schnetz

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Heidelberg Engineering (Germany)(Current)

Marlies Stützle‐Schnetz is an author at Heidelberg Engineering (Germany) specializing in serious adverse events, clinical pharmacokinetics, and pharmacokinetics.

Publications per year

2022–2022

Publications

First‐in‐human, randomized, double‐blind, placebo‐controlled, dose escalation trial of the anti‐herpes simplex virus monoclonal antibody <scp>HDIT101</scp> in healthy volunteers

Antje Blank, Nicolas Hohmann, Marlen Dettmer et al. · Clinical and Translational Science · 2022 · 13 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

1–1 of 1